AAAAAA

   
Results: 1-14 |
Results: 14

Authors: CHOLLET DF GOUMAZ L RENARD A MONTAY G VERNILLET L ARNERA V MAZZO DJ
Citation: Df. Chollet et al., SIMULTANEOUS DETERMINATION OF THE LACTONE AND CARBOXYLATE FORMS OF THE CAMPTOTHECIN DERIVATIVE CPT-11 AND ITS METABOLITE SN-38 IN PLASMA BYHIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY, Journal of chromatography B. Biomedical sciences and applications, 718(1), 1998, pp. 163-175

Authors: SESSA C CALDIERA S DEJONG J MONNERAT C PERARD D VERNILLET L RIVA A BESENVAL M BAUER J
Citation: C. Sessa et al., PHASE-I STUDY OF RPR109881A, A NEW TAXOID ADMINISTERED AS A 3 HOUR INTRAVENOUS-INFUSION TO PATIENTS (PTS) WITH ADVANCED SOLID TUMORS, Annals of oncology, 9, 1998, pp. 603-603

Authors: CALDIERA S BAUER J DEJONG J MONNERAT C PERARD D VERNILLET L RIVA A BESENVAL M SESSA C
Citation: S. Caldiera et al., A CLINICAL AND PHARMACOKINETIC (PK) PHASE-I STUDY OF RPR109881A, A NEW TAXOID ADMINISTERED AS A 3 HOUR INTRAVENOUS-INFUSION TO PATIENTS (PTS) WITH ADVANCED SOLID TUMORS, Annals of oncology, 9, 1998, pp. 359-359

Authors: LATREILLE J GELMON K EISENHAUER E TOLCHER A FISHER B VERNILLET L DAIGNEAULT L HOSTETLERYANOWITZ C LEBECQ A BESENVAL M
Citation: J. Latreille et al., PHASE-I TRIAL OF THE NEW TAXOID RPR 109881A IN A DAY 1 AND 8 INTRAVENOUS (IV) SCHEDULE EVERY 3 WEEKS - AN NCI CANADA CLINICAL-TRIALS GROUP-STUDY, Annals of oncology, 9, 1998, pp. 382-382

Authors: FUMOLEAU P TUBIANAHULIN M SOULIE P DELECROIX V SISTAC F MEFTI F SOULAS F APPIA F LEBECQ A VERGNIOL JC VERNILLET L RIVA A
Citation: P. Fumoleau et al., A DOSE-FINDING AND PHARMACOKINETIC (PK) PHASE-I STUDY OF A NEW FORMULATION OF DOCETAXEL (D) IN ADVANCED SOLID TUMORS, Annals of oncology, 9, 1998, pp. 387-387

Authors: BAKER SD RAVDIN P AYLESWORTH C SMETZER L BRUNO R VERNILLET L PAZDUR R DOYLE G HAMMERSHAIMB L HOOKER E BURRIS HA ECKHARDT SG JOHNSON T KRAYNAK M HAMMOND L RODRIGUEZ G WEISS G ROWINSKY EK
Citation: Sd. Baker et al., A PHASE-I AND PHARMACOKINETIC (PK) STUDY OF DOCETAXEL IN CANCER-PATIENTS WITH LIVER DYSFUNCTION DUE TO MALIGNANCIES, Annals of oncology, 9, 1998, pp. 388-388

Authors: ROUINI MR LOTFOLAHI A STEWART DJ MOLEPO JM SHIRAZI FH VERGNIOL JC TOMIAK E DELORME F VERNILLET L GIGUERE M GOEL R
Citation: Mr. Rouini et al., A RAPID REVERSED-PHASE HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC METHODFOR THE DETERMINATION OF DOCETAXEL (TAXOTERE(R)) IN HUMAN PLASMA USING A COLUMN-SWITCHING TECHNIQUE, Journal of pharmaceutical and biomedical analysis, 17(8), 1998, pp. 1243-1247

Authors: HAAZ MC RIVORY L RICHE C VERNILLET L ROBERT J
Citation: Mc. Haaz et al., METABOLISM OF IRINOTECAN (CPT-11) BY HUMAN HEPATIC MICROSOMES - PARTICIPATION OF CYTOCHROME-P-450 3A AND DRUG-INTERACTIONS, Cancer research, 58(3), 1998, pp. 468-472

Authors: CARCAS AJ FRIAS J HERNANZ A RUBIO ED CORTESFUNES H SASTRE J PAZARES L VERNILLET L MARTIN C HUARTE L
Citation: Aj. Carcas et al., PHARMACOKINETICS OF IRINOTECAN (CPT-11) AND 5-FLUOROURACIL (5-FU) IN A DOSE-FINDING STUDY IN ADULT PATIENTS WITH SOLID TUMORS, European journal of cancer, 33, 1997, pp. 1121-1121

Authors: PAPE D VERNILLET L BELLISSANT E BENTUEFERRER D ALLAIN H
Citation: D. Pape et al., NONINTERCHANGEABILITY OF SPECIFIC RADIOIMMUNOASSAY AND MONOCLONAL-ANTIBODY FLUORESCENT POLARIZATION IMMUNOASSAY IN CYCLOSPORINE MEASUREMENTS, Fundamental and clinical pharmacology, 10(5), 1996, pp. 484-489

Authors: KOVARIK JM VERNILLET L MUELLER EA FREIBURGHAUS R NIEDERBERGER W KUTZ K
Citation: Jm. Kovarik et al., CYCLOSPORINE DISPOSITION AND METABOLITE PROFILES IN RENAL-TRANSPLANT PATIENTS RECEIVING A MICROEMULSION FORMULATION, Therapeutic drug monitoring, 16(5), 1994, pp. 519-525

Authors: VERNILLET L KOVARIK JM FREIBURGHAUS R SCHAUB P MUELLER EA NIEDERBERGER W ZEHENDER H
Citation: L. Vernillet et al., BLOOD CYCLOSPORINE-A AND METABOLITE KINETIC PROFILES AFTER ADMINISTRATION OF SANDIMMUNE SOFT GELATIN CAPSULES AND NEORAL IN TRANSPLANT RECIPIENTS, Transplantation proceedings, 26(5), 1994, pp. 2964-2968

Authors: GARDIER AM MATHE D GUEDENEY X BARRE J BENVENUTTI C NAVARRO N VERNILLET L LOISANCE D CACHERA JP JACOTOT B TILLEMENT JP
Citation: Am. Gardier et al., EFFECTS OF PLASMA-LIPID LEVELS ON BLOOD DISTRIBUTION AND PHARMACOKINETICS OF CYCLOSPORINE-A, Therapeutic drug monitoring, 15(4), 1993, pp. 274-280

Authors: FOSTER RW JUBBER AS HASSAN NAGM FRANKE B VERNILLET L DENOUEL J CARPENTER JR SMALL RC
Citation: Rw. Foster et al., TRIALS OF THE BRONCHODILATOR ACTIVITY OF THE XANTHINE ANALOG SDZ-MKS-492 IN HEALTHY-VOLUNTEERS DURING A METHACHOLINE CHALLENGE TEST, European Journal of Clinical Pharmacology, 45(3), 1993, pp. 227-234
Risultati: 1-14 |